Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine

BackgroundThe mRNA vaccines help protect from COVID-19 severity, however multiple sclerosis (MS) disease modifying therapies (DMTs) might affect the development of humoral and T-cell specific response to vaccination.MethodsThe aim of the study was to evaluate humoral and specific T-cell response, as...

Full description

Bibliographic Details
Main Authors: Federica Dominelli, Maria Antonella Zingaropoli, Matteo Tartaglia, Eeva Tortellini, Mariasilvia Guardiani, Valentina Perri, Patrizia Pasculli, Federica Ciccone, Leonardo Malimpensa, Viola Baione, Anna Napoli, Aurelia Gaeta, Miriam Lichtner, Antonella Conte, Claudio Maria Mastroianni, Maria Rosa Ciardi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1050183/full